Back

Combined CD34⁺ cell frequency and S100A8/A9 profiling improves biological risk stratification in peripheral and carotid atherosclerosis

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Biomechanics in peripheral artery disease Pathophysiology and Mechanisms ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Martina Mutoli Mutoli

IRCCS - MultiMedica, Milan (Italy)

6 More presentations in this session

Presentation thumbnail
Factors associated with wound healing in chronic limb-threatening ischemia patients with hemodynamic failure following endovascular therapy
Doctor O. Iida (Osaka, JP)
Abstract
Presentation thumbnail
Unsupervised clustered-derived phenotyping in carotid artery disease: a novel risk stratification model integrating artificial intelligence algorithm with clinical data
Doctor A. Pinna (Rochester, US)
Abstract
Presentation thumbnail
Pericarotid adipose tissue attenuation is associated with plaque inflammatory markers in symptomatic carotid atherosclerosis
Doctor K. Nogami (Rochester, US)
Abstract
Presentation thumbnail
Pan-immune inflammation value is associated with disease severity in patients with peripheral arterial disease
Doctor O. Gonder (Ankara, TR)
Abstract
Presentation thumbnail
IL4Ralpha signaling delays foam cell formation in atherosclerotic lesions
Doctor J. Kral-Pointner (Vienna, AT)
Abstract

Access the full session

Session thumbnail
Biomechanics in peripheral artery disease

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Prediction of cardiovascular outcomes by subtle changes in the peripheral immune cell landscape - insights from the LURIC single cell RNA-sequencing study (LuRNA)
30 August 2024
thumbnail
Congress Presentation
Role of S100A4 in atherosclerosis development
27 August 2021
thumbnail
Congress Presentation
Role of osteogenic circulating endothelial progenitor cells in dissemination of large arterial calcification in rheumatoid arthritis
2 September 2019
thumbnail
Congress Presentation
High doses of CD34+ cells delivered to patients in the CardiAMP Heart Failure (HF) trial
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources